1. A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. (September 2018) Authors: Sahin, Ugur; Schuler, Martin; Richly, Heike; Bauer, Stefan; Krilova, Anna; Dechow, Tobias; Jerling, Markus; Utsch, Magdalena; Rohde, Christoph; Dhaene, Karl; Huber, Christoph; Türeci, Özlem Journal: European journal of cancer Issue: Volume 100(2018) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms. Issue 3 (16th September 2013) Authors: Wöll, Stefan; Schlitter, Anna Melissa; Dhaene, Karl; Roller, Marc; Esposito, Irene; Sahin, Ugur; Türeci, Özlem Journal: International journal of cancer Issue: Volume 134:Issue 3(2014:Feb. 01) Page Start: 731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Spreading Pattern and Tissue Response to Hyaluronic Acid Gel Injections in the Subcutis: Ultrasound Videos, Ultrasound Measurements, and Histology. (17th January 2020) Authors: Vandeputte, Joan; Leemans, Gaëlle; Dhaene, Karl; Forsyth, Ramses; Vanslembrouck, Jurgen; Hatem, Frank; Micheels, Patrick Journal: Aesthetic surgery journal Issue: Volume 41:Number 2(2021) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Telomerase activity in human pleural mesothelioma. Issue 11 (1st November 1998) Authors: Dhaene, Karl; Hübner, Roland; Kumar-Singh, Samir; Weyn, Barbara; Van Marck, Eric Journal: Thorax Issue: Volume 53:Issue 11(1998) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗